Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interval of Disease Inactivity After Complete Polypoidal Regression on ICGA in Eyes With Polypoidal Choroidal Vasculopathy Following Intravitreous Aflibercept Treatment

NCT04707027 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.

NCT NCT04707027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04707027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interval of Disease Inactivity After Complete Polypoidal Regression on ICGA in Eyes With Polypoidal Choroidal Vasculopathy Following Intravitreous Aflibercept Treatment
Lead sponsor
Chiang Mai University
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2020
Completion date
November 30, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polypoidal choroidal vasculopathy